2019 Cannabis Business Award's Publication of the Year |
THE PREVOIUS E-NEWSLETTER HAD SOME ISSUES WITH LINKS, PLEASE USE THIS E-NEWSLETTER THANK YOU CHARLES FELIX |
WEDNESDAY, NOVEMBER 12, 2025 |
FMCPG HAS BEEN SERVING
AND REPRESENTING THE CANNABIS PHYSICIAN COMMUNITY SINCE 2020 |
THE "FLORIDA MEDICAL CANNABIS PHYSICIAN GROUP" (FMCPG)
FOR ALL "MEDICAL MARIJUANA DOCTORS" AND "MMTC DIRECTORS ONLY " SPECIAL GUEST: JODI JAMES - FL CAN UPDATE FROM TALLAHASSEE
ROBERT FRIEDMAN - CLAB MICHAEL BARENBOYM - WEEDGETS DISCUSS AND UPDATE THE LEGISLATIVE PRIORITIES FOR
2025/2026
REVIEW OF THE OMMU AND CHANGES TO THE DOCTOR'S AND PATIENT INPUT PORTALS ON THE OMMU WEBSITE.
DOCTORS WITHIN OUR GROUP WILL DISCUSS HOW THEY HAVE BEEN WORKING AROUND SOME OF THE CHANGES
REF'S ISSUES AND SOLUTIONS
TIME TO RENEW YOUR MEMBER IN FMCPG
CLICK HERE FOR THE MEMBERSHIP FORM USE THIS LINK TO REGISTER FOR THE NEXT MEETING - WEDNESDAY, DECEMBER 10, 2025 CLICK ON LINK BELOW |
MEDICAL CANNABIS PHYSICIAN PROMOTION PACKAGE FOR 2026 BY CANNABIS NEWS FLORIDA
ARTICLE: Physician will contribute an article of 350 words**. This article will appear in the Cannabis News Florida e-newsletter for one month (4 weeks).
E-MAIL BLAST: Cannabis News Florida will send out one e-mail blast promoting the Physician to the other physicians in three zip code areas or one city to be determined by the Physician. The Physician will supply the information for the email blast. The Article above can be used in the e-mail blast.
The cost of this program is ONLY $399 AND INCLUDES A ONE YEAR MEMBERSHIP IN THE FMCPG - MUST BE PUCHASED BEFORE 12/31/25 **Cannabis News Florida will assign a writer for a telephone interview with the Physician and create the article to be published. Physician shall have the right to review and approve the article before publication for an additional cost of $100. IF YOU ARE INTERESTED, PLEASE EMAIL ME AT CHARLES@CANNABISNEWSFLORIDA.COM OR CALL MY CELL AT 954-605-4785 |
Why Weedgets Smoking Products Are Better for Your Lungs
When it comes to smoking, your lungs deserve protection—and that’s exactly what Weedgets products are designed to deliver. Unlike traditional pipes or joints that expose you to hot smoke and harsh particulates, Weedgets offers a cleaner, smoother, and safer smoking experience engineered for your respiratory health. Advanced Filtration for Cleaner Smoke At the heart of every Weedgets innovation is filtration technology. Weedgets pipes and accessories feature integrated micro-filters that trap impurities and resin particles before they reach your lungs. This significantly reduces exposure to tar, ash, and other combustion byproducts that can irritate your airways and cause coughing. The result is a noticeably cleaner inhale that feels light yet delivers full flavor and potency. Cooling the Smoke to Protect Your Airways
One of the biggest threats to lung comfort is the temperature of the smoke itself. Hot, unfiltered smoke can inflame the delicate tissue lining your respiratory tract. Weedgets addresses this with cooling pathways and diffusion systems that lower smoke temperature before it enters your mouth. By cooling each puff, these devices minimize throat burn and lung irritation, letting you enjoy a smoother and more comfortable session.
Designed for Moisture Retention and Hydration
Traditional smoking dries out your throat and lungs, often leading to post-session irritation. Weedgets’ designs—including the award-winning MAZE-X pipe—use moisture-preserving features that maintain a more balanced humidity level in each draw. This helps reduce dryness and supports the lungs’ natural ability to stay hydrated and clear.
Less Coughing, More Breathing Comfort Many users notice that Weedgets devices help them cough less and breathe more comfortably. That’s because the filtered and cooled smoke allows for deeper, more natural inhales without the harsh hit. Whether you’re a daily smoker or someone who values occasional sessions, Weedgets technology helps you enjoy the benefits of cannabis while protecting your respiratory wellness. Sustainable and Hygienic Design
Weedgets products are built for cleanability and reusability, unlike disposable filters or cheap pipes that accumulate residue and bacteria. Each component can be easily cleaned, ensuring a fresh and sanitary smoking experience every time. This not only supports better lung health but also contributes to a cleaner environment. Science-Driven Innovation Developed by engineers and health-conscious designers, Weedgets represents the future of responsible smoking. Every product is tested and refined to reduce the harmful effects of smoke inhalation while preserving the full sensory and therapeutic experience of cannabis.
In summary: Weedgets isn’t just about better smoking—it’s about smarter smoking. By filtering, cooling, and cleaning each puff, Weedgets protects your lungs so you can enjoy cannabis safely, comfortably, and consciously.
CLICK HERE FOR MORE INFORMATION |
NEWS FROM THE PAST WEEK RELATING TO THE BUSINESS OF
MMTC'S IN FLORIDA Click on Company Logo to be Transferred to Web Site |
Trulieve Reports Third Quarter 2025 Results Demonstrating Operational Discipline and Cash Flow Strength
-Third quarter revenue of $288 million, with 59% gross margin
-Year to date cash flow from operations of $214 million and free cash flow of $173 million*
-Sold over 12.5 million branded products in the third quarter, up 7% compared to last year
Nov. 5, 2025 — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., today announced its results for the quarter ended September 30, 2025. Results are reported in U.S. dollars and in accordance with U.S. Generally Accepted Accounting Principles (GAAP), unless otherwise indicated. Numbers may not sum perfectly due to rounding.
Q3 2025 Financial and Operational Highlights*
-Revenue of $288 million, with 94% of revenue from retail sales.
-Achieved gross margin of 59%, with GAAP gross profit of $170 million.
-Reported net loss attributable to common shareholders of $27 million. Adjusted net loss of $12 million* excludes non-recurring charges, asset impairments, disposals and discontinued operations.
-Achieved adjusted EBITDA of $103 million*, or 36% of revenue, up 7% year over year.
-Generated cash flow from operations of $77 million and free cash flow of $64 million*.
-Cash at quarter end was $458 million.
-Added Chief Financial Officer Jan Reese to the leadership team and appointed Matthew Foulston to the Board of Directors.
-Rewards program members reached 820,000 members as of September 30, 2025. Loyalty members accounted for 77% of transactions during the third quarter.
-Launched new Roll One Clutch All In One vapes in Florida, selling out in under two weeks.
-Expanded distribution of Onward premium THC beverages in Florida and Illinois, launched new Upward THC energy drinks, and introduced five new 10mg flavors.
-Opened one dispensary in Cincinnati, Ohio and relocated one dispensary to Bisbee, Arizona.
*See “Non-GAAP Financial Measures” below for additional information and a reconciliation to GAAP for all Non-GAAP metrics.
Recent Developments
-Announced planned redemption of $368 million of senior secured notes due 2026.
-Launched new mobile app serving Florida customers enabling patients to browse and reserve products, view promotions, and check rewards status through a seamless digital experience.
-Currently operate 232 retail dispensaries and over four million square feet of cultivation and processing capacity in the United States.
Management Commentary
“Our 2025 strategic plan is delivering results, with demonstrable progress on reform, customers, distribution, and branded products,” said Kim Rivers, Trulieve CEO. “Significant flexibility in our core business and strong cash generation continue to set us apart in a dynamic market.”
READ MORE |
Trulieve Announces Notice of Redemption for All US$368 Million of its 8.0% Senior Secured Notes due 2026
Nov. 4, 2025 — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., today announced it has issued a notice of redemption for all of its outstanding 8.0% senior secured notes due 2026 (CUSIP: 89788CAD6 / ISIN: CA89788CAD61) (the “Notes”). The aggregate principal amount of the Notes currently outstanding is US$368,000,000. As set forth in the notice of redemption, the redemption date will be December 5, 2025 (“the Redemption Date”), and the redemption price is 100% of the principal redeemed, plus accrued and unpaid interest up to, but excluding, the Redemption Date. The Notes trade on the Canadian Securities Exchange under the symbol “TRUL.NT.U”. In conjunction with the redemption, the Notes will be delisted from the Canadian Securities Exchange.
On November 4, 2025, a copy of the notice of redemption was issued to record holders. Payment of the redemption price and surrender of the Notes for redemption will be as of December 5, 2025 and will be made through the facilities of Odyssey Trust Company in accordance with the applicable procedures of the trust indenture governing the Notes.
READ MORE |
Trulieve Rewards Trulieve Rewards is a customer rewards program offering patients and customers in participating states an easy platform to earn points on every purchase at Trulieve dispensaries. We've revamped and refreshed our old cannabis loyalty program to reward cannabis enthusiasts loyal to Trulieve with savings, perks, and points every time they shop for cannabis products JOIN NOW |
The Cannabist Company Reports Third Quarter 2025 Results
Nov. 10, 2025– The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) (“The Cannabist Company” or the “Company”), one of the most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today reported its financial and operating results for the third quarter ended September 30, 2025. All financial information presented in this release is in U.S. GAAP, unaudited, and in thousands of U.S. dollars, unless otherwise noted.
“During the third quarter, we demonstrated improvements in some areas of our business, despite a challenging operating environment. A highlight of the third quarter was the start of Adult Use in Delaware on August 1. Retail gross margin improved sequentially as a result of more disciplined discounting, but inventory reduction initiatives in wholesale contributed to sequential gross margin compression. We continued to make progress in footprint optimization, with the opening of our sixth location in Ohio and the sale of three dispensaries in Pennsylvania, as we shift to a wholesale focus in that market and retain exposure for an eventual adult use transition. Subsequent to quarter close, we opened our seventh retail location in Ohio, with one more in development,” said David Hart, CEO of The Cannabist Company.
He continued, “During the quarter, the sale of our three locations in Pennsylvania contributed more than $8 million in net cash to the balance sheet. Subsequent to quarter close, we are pleased to announce the finalization of our exit from the Florida market, with the closing on the sale of our remaining interests for gross proceeds of $11 million. As we have said before, we are focused on managing liquidity and proactively addressing the balance sheet, while continuing the process of optimizing our operating footprint. We will continue to pursue additional measures to take costs out of the business and right-size operations, which may include additional divestitures and other strategic alternatives.”
Top 5 Markets by Revenue in Q3[3]: Colorado, Maryland, New Jersey, Ohio, Virginia
Top 5 Markets by Adjusted EBITDA in Q3[3]: Delaware, Maryland, New Jersey, Ohio, Virginia
READ MORE |
AYR Wellness Announces Result of Article 9 Public Auction, Initiation of Sale of Core Assets to its Senior Lenders
Nov. 11, 2025 — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR”) together with its affiliates and subsidiaries (collectively, the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, announces that the public foreclosure auction (the “Sale”) contemplated by the Restructuring Support Agreement dated July 30, 2025 (the “RSA”), resulted in the credit bid submitted by the Company’s senior noteholders (the “Senior Noteholders”) being deemed the successful bid to acquire ownership through a newly formed acquisition vehicle (“NewCo”) of certain collateral assets and equity interests of specified subsidiaries in Florida, New Jersey, Nevada, Ohio, Massachusetts, Pennsylvania and Virginia (the “Assets”), which collectively represent the core operations of the Company.
Scott Davido, interim Chief Executive Officer of AYR, said, “The completion of the public auction and winning bid by AYR’s Senior Noteholders successfully brings AYR over one of the largest remaining milestones in our restructuring process.”
As further contemplated by the RSA, in the coming days the Company expects to (i) sign a Master Purchase Agreement (the “MPA”), to formally begin the process seeking all the necessary regulatory approvals to transfer ownership of the Assets to NewCo, and (ii) commence proceedings under the Companies’ Creditors Arrangement Act in British Columbia to facilitate a court-supervised winding-down of the existing AYR corporate parent entity.
Odyssey Trust Company, in its capacity as collateral trustee for the Company’s Senior Noteholders, conducted the Sale in accordance with Article 9 of the Uniform Commercial Code, at the direction of Senior Noteholders holding a majority of the outstanding senior notes. The auction for the Sale was held on November 10, 2025, at 10.00 a.m. (Eastern Time) virtually via Zoom.
READ MORE |
Curaleaf Reports Third Quarter 2025 Results: Solid Growth and Robust Cash Generation
Third quarter 2025 net revenue of $320 million
Third quarter 2025 International revenue of $46 million
Third quarter 2025 adjusted gross profit margin(1) of 50%
Year-to-date operating and free cash flow from continuing operations of
$104 million and $57 million, respectively
Nov. 5, 2025 — Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer products in cannabis, today reported its financial and operating results for the third quarter ended September 30, 2025. All financial information is reported in accordance with U.S. generally accepted accounting principles (“U.S. GAAP” or “GAAP”) and is provided in U.S. dollars unless otherwise indicated.
Boris Jordan, Chairman and CEO of Curaleaf, stated, “We generated third quarter revenue of $320 million, up 2% sequentially. Price compression continued to be a headwind, yet our domestic segment remained stable and achieved modest growth. Our international segment continued its strong trajectory, delivering 12% sequential growth and 56% year-over-year growth. Adjusted gross margin improved to 50%, an increase of 115 basis points both sequentially and versus the prior year. Adjusted EBITDA was $69 million, representing a 22% margin, inclusive of a 200 basis point drag from our international and hemp businesses. We ended the quarter with $107 million in cash, after paying $28 million in principal and interest debt obligations. We generated $53 million in operating cash flow from continuing operations and $37 million in free cash flow from continuing operations during the third quarter. Subsequent to quarter-end, we made $30 million in acquisition-related debt payments, leaving approximately $70 million payable over the next two years. We also closed on an upsized $100 million revolving line of credit with Needham Bank, giving us greater flexibility to manage our business and pay down more expensive debt.”
Mr. Jordan continued, “The ‘Return to Our Roots’ plan we initiated 12 months ago – which is focused on enhancing product quality, driving growth, expanding margins, and optimizing cash flow – is delivering tangible results. Over the past year, we have completed significant foundational work to reset the business — leveraging our Dark Heart genetics program, investing in our supply chain, and realigning our retail operations. These actions have positioned our domestic business for renewed growth while supporting rapid international expansion. I’m encouraged to report that we’re seeing positive momentum across the organization, despite ongoing macro pressures.”
READ MORE |
Green Thumb Industries Reports Third Quarter 2025 Results
Nov. 05, 2025 — Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today reported its financial results for the quarter ended September 30, 2025. Financial results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”), and all currency is in U.S. dollars.
Highlights for the third quarter ended September 30, 2025:
-Revenue of $291.4 million, an increase of 1.6% over the prior year.
-Cash at quarter end totaled $226.2 million.
-GAAP net income of $23.3 million or $0.10 per basic and diluted share, excluding the one-time gain on asset sales, GAAP net income would have been $9.7 million or $0.04 per basic and diluted share.
-Adjusted EBITDA of $80.2 million or 27.5% of revenue.
-Cash flow from operations of $74.1 million.
-Authorized $50 million for the repurchase of Subordinate Voting Shares from September 23, 2025 to September 22, 2026.
-Commenced adult-use cannabis sales at seven of eight RISE Dispensaries in Minnesota on September 17, 2025.
-Subsequent to quarter end, the eighth Minnesota RISE Dispensary commenced adult-use on October 21, 2025.
MANAGEMENT COMMENTARY
Green Thumb Founder, Chairman and Chief Executive Ben Kovler
“Despite ongoing price compression in certain key markets, our team delivered another solid quarter of results. Third quarter revenue was $291 million, up approximately 2% year over year. Adjusted EBITDA was $80 million, or 28% of revenue, and cash flow from operations was $74 million. Our balance sheet is in comfortable shape with cash and cash equivalents of $226 million, and our senior credit facility does not mature for four years.
“As we have said, maintaining a strong balance sheet and generating consistent cash flow gives us the flexibility to allocate capital effectively, and returning value to our shareholders is a key part of that approach. Since launching our first share repurchase program in late 2023, we have repurchased approximately $107 million of our subordinate voting shares at an average price of $7.95 per share, reducing total shares outstanding by 13.5 million. In September, our Board authorized another share repurchase program for $50 million that extends through September 2026.
“Our strong financial position also provides the headroom to stay forward-thinking amid persistent industry challenges. While federal reform remains uncertain and 280E taxation and limited access to capital continue to weigh on operators, cannabis demand continues to rise, making it one of the largest and fastest-growing consumer categories.
“In August, we completed a transaction with RYTHM, Inc. that further enables expansion of THC products beyond dispensary walls and strengthens Green Thumb’s position in a rapidly evolving industry. As the THC market continues to expand, we are excited to lead this next phase of growth, supported by strong brands, loyal customers, industry-leading products and, of course, the best team in the business driving it all forward.”
READ MORE |
Cresco Labs Delivers Strong Q3, Maintains Market Leadership, and Unlocks New Growth Opportunities
NOVEMBER 5, 2025 — Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the third quarter ended September 30, 2025. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company’s investor website, here.
Third Quarter 2025 Highlights
-Third quarter revenue of $165 million. Third quarter operating cash flow of $6 million.
-Gross profit of $79 million. Adjusted gross profit 1 of $80 million; and an Adjusted gross margin 1 of 48.8%.
-SG&A of $52 million or 31.3% of revenue.
-Net loss of $22 million, includes a $16 million loss for debt extinguishment related to the refinancing of the Company’s senior secured term loan, and non-cash impairment charges of $2 million related to California assets being considered held for sale.
-Third quarter Adjusted EBITDA 1 of $40 million and Adjusted EBITDA margin 1 of 24.1%.
-Retained the No. 1 share position in multiple billion dollar markets. 2
Management Commentary
“In Q3, we refinanced our debt and strengthened our balance sheet while delivering solid results and maintaining leadership across key markets through disciplined execution. Our proven retail and wholesale capabilities continue to drive profitability, while new dispensaries in Ohio, expansion into Kentucky, and our upcoming product launch in Germany are unlocking compelling avenues for growth. Together, these initiatives position Cresco Labs to outperform the market and create lasting shareholder value.”
“The cannabis industry is entering a new phase of growth and consolidation, and Cresco Labs is prepared to lead. Operators with scale, efficiency, and discipline will define the next chapter. By leveraging our core assets and operational excellence, we’re building an emerging growth platform designed to create long-term value, both within and beyond regulated U.S. cannabis.”
READ MORE |
FLUENT Cannabis Launches Limited-Edition Holiday MOODS Reindeer Reefer and Festivus Frost-flavored vapes
Nov. 11, 2025 — FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), today announced the launch of two limited-edition holiday MOODS distillate vape flavors — Reindeer Reefer and Festivus Frost – into Florida’s retail network. Each strain is offered in 1g MOODS Mini all-in-one vape devices, accompanied by an exclusive holiday-themed mini sleeve and lanyard, making them the perfect collectible for cannabis enthusiasts celebrating the season.
Festivus Frost
Lift your holiday spirits with the crisp piney mint coolness of Festivus Frost MOODS. Derived from Jack Herer, this Sativa-leaning hybrid will snap your senses into a focused and creative cerebral state.
Type: Sativa Leaning Hybrid
Origin: Jack Herer
Flavor: Crisp Piney Peppermint
Mood: Holiday Parties, Decorating, Walking through an Enchanted Winter Forest
READ MORE |
Verano Announces Exclusive Partnership with Raw Garden, a Leading California Cannabis Operator, to Launch Raw Garden Branded Products in New Jersey
Raw Garden Live Resin Terpene Cartridges and All-in-One Vapes will be sold at Verano’s Four New Jersey Zen Leaf dispensaries and third-party retailers beginning November 11th.
Nov. 06, 2025 — Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced an exclusive partnership with Raw Garden, a cultivator and producer of pure cannabis products balancing flavor and potency, to bring a suite of the California-based company’s premier products to New Jersey consumers. Beginning November 11, Raw Garden will debut its cartridges and All-in-Ones at Verano’s four Zen Leaf dispensaries in New Jersey and third-party dispensaries across the Garden State.
For over 15 years, Raw Garden has set the standard for clean cannabis with a focus on innovation, transparency, and sustainable farming practices. Through this exclusive partnership, Verano will produce seven of Raw Garden’s most sought-after strains, including Blue Dream, Green Crack, Dosi Punch, Blueberry Cookies, Sunset Funk, Orange Runtz and Rosé.
“As one of California’s most popular cannabis brands, our exclusive partnership with Raw Garden is an incredible opportunity to bring some of the most beloved West Coast products to the East Coast for New Jersey cannabis consumers,” said George Archos, Verano founder and Chief Executive Officer. “With the continued growth of the vape category, this partnership bolsters the expansive portfolio of vape products we’ve launched throughout 2025, and we look forward to introducing Raw Garden’s award-winning products to Garden State cannabis connoisseurs.”
READ MORE |
iAnthus Continues Expansion in Florida with GrowHealthy Dispensary Opening in Fort Myers
Grand Opening Celebrates Expansion of Patient Access to Premium Medical Products, New Brands and Elevated Shopping Experience
Nov. 05, 2025 — iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCID: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, has announced its expansion into Fort Myers with the opening of its 24th GrowHealthy dispensary in Florida.
The new location opens its doors today with an expanded lineup of premium product brands, including The Vault, Sunshine State and MPX, offering patients greater choice and quality all under one roof.
“We’re thrilled to introduce GrowHealthy to the Fort Myers community,” said Richie Proud, CEO at iAnthus. “Each new opening is an opportunity to bring our mission to life–broadening access to safe, high-quality cannabis and deepening our connection to patients across the Sunshine State. This store was designed to feel distinctly local, while still embodying the care, consistency and premium experience that GrowHealthy has become known for.”
GrowHealthy continues to set itself apart through a focus on whole-plant wellness, premium genetics and community connection. Built on the foundation of cultivators and caregivers, the company leads with a flower-first philosophy, strong community ties, and a deep respect for the cannabis plant. The Fort Myers dispensary offers an extensive menu of products–including flower, vapes, concentrates and other formats–crafted to meet the local community’s diverse wellness needs.
READ MORE |
This week's Viridian Chart of the Week explores the Uncertain Tax Liabilities (UTLs) of eight large MSOs. UTLs are the long-term liability account where MSOs accrue their expensed but unpaid 280E tax liabilities. The amount of these liabilities continues to grow, and the companies on the Chart have a current aggregate of $2.1 billion on their balance sheets.
The Chart examines two methods for assessing the size of tax liabilities. The orange line measures the YTD net additions to UTL’s relative to Cash Flow from Operations, and the green bars depict the UTLs on each company’s balance sheet relative to their consensus 2026 EBITDA.
The orange line indicates that approximately 104% of the YTD cash flow from operations for the companies on the Chart would be eliminated if the companies were actually paying the tax expense they report on their income statements. Aggregate cash flow from operations for the YTD period would be negative for the companies on the Chart. Some companies, like Jushi and Verano, would have sharply negative cash flow from operations if they were paying their 280E taxes. Note that the orange line is missing on Vireo because Vireo shows a negative CFFO on its June 10-Q (Q3 not yet filed), even after accruing 280E taxes.
The green bars represent the balance sheet amounts of 280E liabilities in relation to consensus 2026 EBITDA. There is a wide range of values, ranging from .5x for Vireo up to 3x for Jushi, with an aggregate average of 1.3x.
|
What happens to these accrued liabilities when, and if, 280E is eliminated? One outcome seems exceedingly unlikely to us – that these liabilities will be erased and forgiven. That doesn’t seem to be in the IRS DNA.
Another popular speculation is that they will be negotiated out at pennies on the dollar. Proponents of that viewpoint cite the 2022 settlement between Harborside and the IRS, wherein Harborside agreed to pay $5.8 million on a claimed liability of $22 million, with scheduled payments of $50k per month. Advocates of this position overlook the fact that the IRS settled this as a collection matter; they never forgave the debt, but recognized that it was tantamount to getting blood from a turnip, as Harborside was too broke to pay much. The lesson here is that companies like those on the Chart are unlikely to get a deeply discounted settlement amount.
The most likely case is that some of this debt will drop off due to the statute of limitations. The IRS has three years from the original due date of the return to assess a tax. We will likely be approaching some deadlines by the time 280E is eliminated, and companies may be looking to run out the clock. The magnitudes of the liabilities, however, suggest that the IRS should institute a multi-year payment plan. After all these liabilities average 1.4x EBITDA, which would be impossible to pay in one year in the ordinary course of business.
|
For More Analysis View This Week's Viridian Chart of the Week About Viridian Capital Advisors
Since launching in 2014, Viridian Capital Advisors has become one of the most respected and experienced advisory and M&A firms specializing in the cannabis industry. We provide a wide range of services, including: Strategic Advisory Consulting: Including valuation, financial modeling, restructuring and fairness opinions.
Mergers & Acquisitions: Transaction advisory and execution. Capital Raises: Including debt and equity. Many of our assignments begin with a basic question: "What should I do now?" Raise capital to expand? What kind of capital is most appropriate?
Acquire another company? What are the advantages and pitfalls?
Sell my company? What valuations can i achieve? What transaction structures are possible?
Put our experience, data and depth of senior talent behind your next transaction.
Contact
Scott Greiper
CEO
Viridian Capital Advisors, LLC
646.330.0704
sgreiper@viridianca.com
Frank Colombo
Managing Director
Viridian Capital Advisors, LLC
914.523.4730
fcolombo@viridianca.com
|
NATIONAL AND INTERNATIONAL NEWS |
Canopy Growth Reports Second Quarter Fiscal 2026 Financial Results; Company Continues to Strengthen Financial Performance with Improving Adjusted EBITDA, Disciplined Cost Management, and a Stronger Balance Sheet
Canada adult-use revenue up 30% in Q2 FY2026 and 37% year-to-date, reflecting the benefits of our focused commercial strategy and more disciplined execution
Canada medical revenue up 17% in Q2 FY2026 and 15% year-to-date, marking another standout quarter for growth
$298MM cash and cash equivalents, which exceeds debt balances by $70MM at September 30, 2025; as a result, conditions that previously raised substantial doubt concerning the Company’s ability to continue as a going concern have been resolved
Canopy Growth Reports Second Quarter Fiscal 2026 Financial Results; Company Continues to Strengthen Financial Performance with Improving Adjusted EBITDA, Disciplined Cost Management, and a Stronger Balance Sheet
SMITHS FALLS, ON, November 7, 2025 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED) (Nasdaq: CGC) today announced its financial results for the second quarter ended September 30, 2025 (“Q2 FY2026”). All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.
“We’re building a stronger, more competitive company defined by continued momentum in Canada adult-use cannabis, consistent growth in Canada medical cannabis, and a disciplined approach to strengthening our balance sheet. Together, these actions give me confidence in our ability to sustain progress and deliver results for quarters to come.”
Luc Mongeau, Chief Executive Officer
“Our financial discipline continues to improve our path to profitability. Through cost reductions, margin expansion, and balance sheet strength, we’re building a more resilient company poised for long term success.”
Tom Stewart, Chief Financial Officer
READ MORE |
MariMed Reports Third Quarter 2025 Earnings
NORWOOD, Mass., Nov. 05, 2025 — MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the third quarter ended September 30, 2025.
Management Commentary
“During the third quarter, we continued to make progress on our plan to own top-selling, national consumer cannabis brands, while also delivering sequential increases in revenue, adjusted EBIDTA, and operating cash flow,” said Jon Levine, MariMed Chief Executive Officer. “We had another strong quarter of wholesale sales, which is a core component of our ‘Expand the Brand’ growth strategy. Another critical part of the strategy is to bring our innovative, top-selling brand portfolio to new markets in high-growth states. New agreements we announced during and after the third quarter will widen distribution of our brands to Maine, Pennsylvania, and New York.”
“We delivered sequential growth in both wholesale and retail revenues for the third quarter, and reported a substantial increase in adjusted net income,” said Mario Pinho, MariMed Chief Financial Officer. ““Wholesale expansion in Massachusetts and Illinois, the launch of adult-use sales in Delaware, and higher retail transactions across our network fueled topline growth. While new competition impacted our Metropolis, Illinois location, we improved profitability through disciplined cost management and operational efficiencies, without compromising product quality or the customer experience.”
READ MORE |
BELOW ARE THE LINKS TO THE DIRECTORY OF FLORIDA CANNABIS DOCTORS AND
DISPENSARIES IN THE STATE OF FLORIDA |
QUALIFIED PATIENTS
OVER 931,000
AND 734 DISPENSING LOCATIONS |
LATEST OMMU REPORTS FROM OFFICE OF MEDICAL MARIJUANA USE IN THE STATE OF FLORIDA Highlights from
NOVEMBER 7, 2025 Report BY THE NUMBERS
Qualified Patients: (Active ID Card) NOV 07 2025 931,117 OCT 31 2025 931,266
OCT 24 2025 930,628
OCT 17 2025 930,093
OCT 10 2025 928,083
OCT 03 2025 926,467
Patients Last Week: -149
Qualified Ordering Physicians: 2,458 New Doctors Last Week: 5 Reporting Period: OCT 31 - NOV 6, 2025
Amount of Medical Marijuana Dispensed - (mgs THC) 411,944,749
Amount of Low-THC Cannabis Dispensed - (mgs CBD) 145
Amount of Marijuana in a From for Smoking (oz) 141,629.592
Approved Dispensing Locations: 734 Added Last Week: 1 GROWHEALTHY - FORT MYERS |
UPCOMING MEETING AND CONFERENCES LOOK FOR IN FUTURE ISSUES |
ADVERTISEMENT OPPORTUNITIES
If your goal is to get your business in front of the right people in the cannabis industry or you want to be an integral part of this new and exciting business opportunity, then you need to join with Cannabis News Florida as we help to establish cannabis as a major part of the economy in Florida. Cannabis News Florida is an online publication focusing on both local and national news from leading authorities about the medical and business developments in the medical cannabis industry covering the entire state of Florida.
Join the Cannabis News Florida force online and in print. We offer several marketing options to fit all budgets:
· MMTC PROMOS LISTED IN EACH E-NEWSLETTER
• Directory Listing
• Banner Ads
• Ad Space in the Newspaper
• Feature Articles
• Weekly Newsletters
For further information or to make your ad reservation, please call:561-368-6950 / 954-605-4785 cell charles@cannabisnewsflorida.com
|
|
|